Impact of Poor Tolerance and Discontinuation of the Dexamethasone during Treatment with Lenalidomide-Dexamethasone in Relapsed and Refractory Multiple Myeloma - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Blood Année : 2015

Impact of Poor Tolerance and Discontinuation of the Dexamethasone during Treatment with Lenalidomide-Dexamethasone in Relapsed and Refractory Multiple Myeloma

Résumé

55th Annual Meeting and Exposition of the American-Society-of-Hematology - New Orleans, LA 2013
Fichier non déposé

Dates et versions

hal-01290429 , version 1 (18-03-2016)

Identifiants

  • HAL Id : hal-01290429 , version 1

Citer

Stephanie Guidez, Guillemette Fouquet, Helene Demarquette, Morgane Nudel, Eileen Boyle, et al.. Impact of Poor Tolerance and Discontinuation of the Dexamethasone during Treatment with Lenalidomide-Dexamethasone in Relapsed and Refractory Multiple Myeloma. Blood, 2015, 126 (23), pp.5379. ⟨hal-01290429⟩
125 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More